What’s New in Pediatric Brain Tumor Research and Care?

Mark W. Kieran, MD, PhD, director of Pediatric Medical Neuro-Oncology at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, spoke to pediatric patient families in a recent Facebook Live Webchat addressing pediatric brain tumor care.

Kieran answered questions from audience members about the most common of the 300 brain tumor types that occur in children, including low grade gliomas, medulloblastomas, diffuse intrinsic pontone gliomas, and ependymomas.

“Brain tumors in kids are fundamentally different than those in adults,” Kieran said, explaining that a child’s tumor may have the same microscopic appearance to an adult tumor, but the mutations that cause its growth are completely different.

As young children’s bodies are still growing, large doses of radiation therapy and chemotherapy to treat tumors can be harmful to their long-term cognitive and physical development. Kieran explained his team’s progress in precision medicine, which screens for unique mutations in each child’s tumor and uses drugs to specifically target them, and novel experimental therapies — including immunotherapy, focused ultrasound therapy, and proton radiation. He is hopeful these methods will successfully treat children while improving their quality of life.

“We’re going to start to see much better cure rates [at] much lower toxicity and much better…cognitive and functional outcomes,” he said. “That’s going to be the true measure of success.”

View a video of the May 22 webchat below.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
WATCH LIVE: Sarah Nikifrow, MD, PhD, discusses FDA approval of drug to treat adults with non-Hodgkin lymphoma: https://t.co/t1m14izqBK
Dana-Farber @danafarber
RT @KristyNBCBoston: Tonite @nbcboston news at 5, I speak w/Dr. Jacobson @DanaFarber. Car T-cell therapy gives hope to those who've run out…

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.